Caifang Ni
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 13
-
- Radiomics and Machine Learning in Medical Imaging 3
-
- Cancer, Hypoxia, and Metabolism 5
- MicroRNA in disease regulation 3
- Cancer, Lipids, and Metabolism 2
-
- Cancer Mechanisms and Therapy 5
-
- Liver Disease Diagnosis and Treatment 3
-
- Characterization and Applications of Magnetic Nanoparticles 2
- Journals
- Chemical Engineering Journal (1 paper)Journal of Controlled Release (1 paper)Medical Physics (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Caifang Ni
28 papers receiving 378 citations
Peers
Comparison fields: 5 of 81
- Hepatology 62
- Biomaterials 59
- Health Informatics 5
- Radiology, Nuclear Medicine and Imaging 82
- Cancer Research 48
Countries citing papers authored by Caifang Ni
This map shows the geographic impact of Caifang Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caifang Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caifang Ni more than expected).
Fields of papers citing papers by Caifang Ni
This network shows the impact of papers produced by Caifang Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caifang Ni. The network helps show where Caifang Ni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Caifang Ni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 12 | |
| 9 | 2021 | 11 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 68 | |
| 12 | 2020 | 10 | |
| 13 | 2019 | 31 | |
| 14 | 2019 | 7 | |
| 15 | 2019 | 10 | |
| 16 | 2018 | 8 | |
| 17 | 2018 | 5 | |
| 18 | 2017 | 1 | |
| 19 | 2015 | 5 | |
| 20 | 2011 | 4 |
About Caifang Ni
Caifang Ni is a scholar working on Hepatology, Cancer Research and Pathology and Forensic Medicine, having authored 30 papers that have together received 384 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer Mechanisms and Therapy (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Liver Disease Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (3 papers), Cancer, Lipids, and Metabolism (2 papers) and Characterization and Applications of Magnetic Nanoparticles (2 papers). The work is most often cited by research in Hepatology (62 citations), Biomaterials (59 citations) and Health Informatics (5 citations). Caifang Ni has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Zhuang Liu, Liang Cheng, Nailin Yang, Fei Gong, Huali Lei, Ziliang Dong, Zhanhui Wang, Xin Gao, Wei Li and Wansheng Wang. Their work appears in journals such as Chemical Engineering Journal, Journal of Controlled Release and Medical Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.